RVLPQ — RVL Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $38.61m
- $49.72m
Brief: Osmotica Pharmaceuticals PLC Reports Third Quarter 2021 Results And Provides Business Update
Osmotica Pharmaceuticals PLC expected to post a loss of 31 cents a share - Earnings Preview
Brief: Osmotica Pharma Files Prospectus Relates To Resale Up To 6.1 Million Ordinary Shares
Brief: Osmotica Pharmaceuticals PLC Announces Debt Financing From Athyrium Capital Management Of Up To $100 Mln
Osmotica Pharma plummets on $35 mln stock, warrants offering
Brief: Osmotica Pharmaceuticals Announces Pricing Of $35 Mln Underwritten Public Offering
Brief: Osmotica Pharmaceuticals PLC Enters Into A Note Purchase Agreement
Brief: Osmotica Pharmaceuticals PLC Announces Proposed Underwritten Public Offering
Brief: Osmotica Pharmaceuticals Says On Sept 8, Co Entered Into Sales Agreement With Cantor Fitzgerald & Co
Osmotica Pharmaceuticals PLC reports results for the quarter ended in June - Earnings Summary
Brief: Osmotica Pharmaceuticals Posts Qtrly Loss Per Share $0.28
Osmotica Pharmaceuticals PLC expected to post a loss of 14 cents a share - Earnings Preview
Osmotica Pharmaceuticals PLC expected to post a loss of 14 cents a share - Earnings Preview
Osmotica Pharmaceuticals PLC expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Fedex, Nike, Carmax, Virgin Galactic
Osmotica Pharma surges on deal to sell legacy business
Brief: Osmotica Pharmaceuticals PLC Announces Conclusion Of Strategic Process With Agreement For The Sale Of Legacy Business To Alora Pharmaceuticals, Llc
Osmotica Pharmaceuticals PLC reports results for the quarter ended in March - Earnings Summary
Brief: Osmotica Pharmaceuticals PLC Reports First Quarter 2021 Results And Provides Business Update